Literature DB >> 2993984

A psychophysical analysis of morphine analgesia.

D D Price1, A Von der Gruen, J Miller, A Rafii, C Price.   

Abstract

Intravenous administration of 0.04-0.08 mg/kg morphine sulfate reduced both sensory intensity and unpleasantness visual analogue scale (VAS) responses to graded 5 sec nociceptive temperature stimuli (45-51 degrees C) in a dose-dependent manner. The lower doses of morphine (0.04 and 0.06 mg/kg) resulted in statistically reliable reductions in affective but not sensory intensity VAS responses, possibly reflecting supraspinal effects on brain regions involved in affect and motivation. However, the highest dose of morphine tested (0.08 mg/kg) reduced both sensory and affective VAS responses to graded nociceptive stimuli as well as VAS sensory responses to first and second pain evoked by brief heat pulses. Morphine also had an especially potent inhibitory effect on temporal summation of second pain that is known to occur when intense nociceptive stimuli occur at rates greater than 0.3/sec. The results support current hypotheses about neural mechanisms of narcotic analgesia and further clarify the relative effects of morphine on sensory and affective dimensions of experimental pain. The derived morphine dose-analgesic response functions also provide a reference standard for quantitatively comparing magnitudes of different CNS-mediated forms of analgesia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993984     DOI: 10.1016/0304-3959(85)90026-0

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  52 in total

1.  Pain variability in fibromyalgia is related to activity and rest: role of peripheral tissue impulse input.

Authors:  Roland Staud; Michael E Robinson; Elizabeth E Weyl; Donald D Price
Journal:  J Pain       Date:  2010-05-07       Impact factor: 5.820

2.  Psychophysical features of the transition from pure heat perception to heat pain perception.

Authors:  S Lautenbacher; A Möltner; F Strain
Journal:  Percept Psychophys       Date:  1992-12

Review 3.  The pharmacological basis of opioids.

Authors:  Carla Ghelardini; Lorenzo Di Cesare Mannelli; Enrica Bianchi
Journal:  Clin Cases Miner Bone Metab       Date:  2015-12-29

4.  DAMGO in the central amygdala alleviates the affective dimension of pain in a rat model of inflammatory hyperalgesia.

Authors:  R-X Zhang; M Zhang; A Li; L Pan; B M Berman; K Ren; L Lao
Journal:  Neuroscience       Date:  2013-08-28       Impact factor: 3.590

5.  The subjective experience of pain: where expectations become reality.

Authors:  Tetsuo Koyama; John G McHaffie; Paul J Laurienti; Robert C Coghill
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

6.  Functional interaction between medial thalamus and rostral anterior cingulate cortex in the suppression of pain affect.

Authors:  S E Harte; C A Spuz; G S Borszcz
Journal:  Neuroscience       Date:  2010-10-27       Impact factor: 3.590

7.  Contribution of the periaqueductal gray to the suppression of pain affect produced by administration of morphine into the intralaminar thalamus of rat.

Authors:  Elizabeth M Munn; Steven E Harte; Alexander Lagman; George S Borszcz
Journal:  J Pain       Date:  2009-02-23       Impact factor: 5.820

8.  Specifying the non-specific factors underlying opioid analgesia: expectancy, attention, and affect.

Authors:  Lauren Y Atlas; Joseph Wielgosz; Robert A Whittington; Tor D Wager
Journal:  Psychopharmacology (Berl)       Date:  2013-10-06       Impact factor: 4.530

9.  Separating analgesia from reward within the ventral tegmental area.

Authors:  E Schifirneţ; S E Bowen; G S Borszcz
Journal:  Neuroscience       Date:  2014-01-13       Impact factor: 3.590

10.  Affective analgesia following muscarinic activation of the ventral tegmental area in rats.

Authors:  Robert G Kender; Steven E Harte; Elizabeth M Munn; George S Borszcz
Journal:  J Pain       Date:  2008-04-03       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.